Xu Siyang, Yin Wen, Zhang Yuling, Lv Qimei, Yang Yijun, He Jin
State Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, Hubei, China.
Cancers (Basel). 2020 Feb 6;12(2):372. doi: 10.3390/cancers12020372.
Colorectal cancer (CRC) is the second most commonly diagnosed cancer and the third cause of cancer death in the world, while intestinal microbiota is a community of microbes living in human intestine that can potentially impact human health in many ways. Accumulating evidence suggests that intestinal microbiota, especially that from the intestinal bacteria, play a key role in the CRC development; therefore, identification of bacteria involved in CRC development can provide new targets for the CRC diagnosis, prevention, and treatment. Over the past decade, there have been considerable advances in applying 16S rDNA sequencing data to verify associated intestinal bacteria in CRC patients; however, due to variations of individual and environment factors, these results seem to be inconsistent. In this review, we scrutinized the previous 16S rDNA sequencing data of intestinal bacteria from CRC patients, and identified twelve genera that are specifically enriched in the tumor microenvironment. We have focused on their relationship with the CRC development, and shown that some bacteria could promote CRC development, acting as foes, while others could inhibit CRC development, serving as friends, for human health. Finally, we highlighted their potential applications for the CRC diagnosis, prevention, and treatment.
结直肠癌(CRC)是全球第二大常见诊断癌症和第三大致癌死亡原因,而肠道微生物群是生活在人类肠道中的微生物群落,可能在许多方面影响人类健康。越来越多的证据表明,肠道微生物群,尤其是肠道细菌中的微生物群,在结直肠癌的发展中起关键作用;因此,鉴定参与结直肠癌发展的细菌可为结直肠癌的诊断、预防和治疗提供新的靶点。在过去十年中,应用16S rDNA测序数据来验证结直肠癌患者相关肠道细菌方面取得了相当大的进展;然而,由于个体和环境因素的差异,这些结果似乎并不一致。在本综述中,我们仔细研究了先前结直肠癌患者肠道细菌的16S rDNA测序数据,并鉴定出在肿瘤微环境中特异性富集的12个菌属。我们关注了它们与结直肠癌发展的关系,并表明一些细菌可促进结直肠癌发展,对人类健康而言是“敌人”,而另一些细菌可抑制结直肠癌发展,是“朋友”。最后,我们强调了它们在结直肠癌诊断、预防和治疗中的潜在应用。